Journal: iScience

Article Title: Multi-omics analyses provide insights into the sulfur metabolism of a novel deep-sea sulfate-reducing bacterium

doi: 10.1016/j.isci.2024.110095

Figure Lengend Snippet: Isolation, morphology, and phylogenetic analyses of Pseudodesulfovibrio serpens zrk46 (A) Diagram showing the strategy used to isolate deep-sea SRB. (B) TEM observation of the morphology of strain zrk46. Scale bar, 2.0 μm. (C) Phylogenetic analysis of strain zrk46. Phylogenetic placement of strain zrk46 within the genus Pseudodesulfovibrio , based on almost complete 16S rRNA gene sequences. The NCBI accession number for each 16S rRNA gene is indicated after each corresponding strain’s name. The tree was inferred and reconstructed using the maximum likelihood criterion. Bootstrap values are based on 1,000 replicates. The 16S rRNA gene sequence of Escherichia coli ATCC 11775 T was used as the outgroup. Bar, 0.02 substitutions per nucleotide position.

Article Snippet: The 16S rRNA gene sequence of Escherichia coli ATCC 11775 T was used as the outgroup.

Techniques: Isolation, Sequencing

Journal: Journal of medical microbiology

Article Title: Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli.

doi: 10.1099/jmm.0.05009-0

Figure Lengend Snippet: Fig. 1. Displacement study: changes in adhesion of E. coli ATCC 11775 and S. typhimurium ATCC 14028 when incubated with respective lactobacillus for different incubation time-periods. r, LGG+E. coli ATCC 11775; j, LGG+S. typhimurium ATCC 14028; m, LCS+S. typhimurium ATCC 14028.

Article Snippet: GI bacterium Change in adhesion, mean SD (%) Competition Exclusion Displacement E. coli O157 56·59 30·77 4·09 17·63 2·62 6·28 E. coli ATCC 11775 57·14 3·54* 4·20 2·81 6·11 1·74 E. coli TG-1 48·62 3·40* 1·73 2·69 0·55 7·38 S. enteritidis ATCC 13076 30·70 14·36* 19·72 12·90 13·04 10·35 S. typhimurium ATCC 14028 42·96 10·16* 36·28 6·61* 10·56 6·07 S. typhimurium E10 62·41 6·39* 27·35 3·75* 0·32 2·70 S. typhimurium E12 24·23 9·32* 15·86 8·73* 22·62 8·19 ‘S. bellurup’ E23 8·67 5·89 12·80 6·78 18·90 5·44 *Significantly different from control (Student’s t-test: P , 0·05).

Techniques: Incubation

Journal:

Article Title: Geminal dialkyl derivatives of N -substituted pantothenamides: Synthesis and antibacterial activity

doi: 10.1016/j.bmc.2011.02.053

Figure Lengend Snippet: Structure of pantothenic acid and N-substituted pantothenamides

Article Snippet: A preliminary screen of these pantothenamides against other strains ( Acinetobacter baumannii ATCC 19606, Klebsiella penumoniae ATCC 13883, Escherichia coli ATCC 25922 and 11775, and Bacillus subtilis ATCC 6051 and 6633) using the agar diffusion method suggests no antimicrobial activity (inhibition zone <1.1 cm for a 1 cm disc impregnated with the desired compound). table ft1 table-wrap mode="anchored" t5 caption a7 MIC (μM) a S. aureus b MRSA c Open in a separate window 9a 7 ± 6 7± 3 Open in a separate window 9b 13 ± 7 13± 2 Open in a separate window 9c 101 ± 45 51 ± 15 Open in a separate window 9d 374 ± 187 374 ± 153 Open in a separate window 9e >715 >715 Open in a separate window 9f 3.2 ± 0.8 3.2 ± 0.9 Open in a separate window 9g >703 >703 Open in a separate window 9h >744 >744 Open in a separate window 9i 376 ± 217 376 ± 109 Open in a separate window 9j 1 ± 0.9 1 ± 0.7 Open in a separate window 9k(N5-pan) 7 ± 2 7 ± 2 Open in a separate window 9l (N9-pan) 0.4 ± 0.2 0.4 ± 0.2 Open in a separate window 9m 24 ± 14 24 ± 14 Open in a separate window a Minimum inhibitory concentrations (MICs) were determined using the following concentrations: 0.5, 1, 2, 4, 8, 16, 32, 64, 128, and 256 μg/mL.

Techniques:

Journal:

Article Title: Geminal dialkyl derivatives of N -substituted pantothenamides: Synthesis and antibacterial activity

doi: 10.1016/j.bmc.2011.02.053

Figure Lengend Snippet: Synthetic route to new N-substituted pantothenamides

Article Snippet: A preliminary screen of these pantothenamides against other strains ( Acinetobacter baumannii ATCC 19606, Klebsiella penumoniae ATCC 13883, Escherichia coli ATCC 25922 and 11775, and Bacillus subtilis ATCC 6051 and 6633) using the agar diffusion method suggests no antimicrobial activity (inhibition zone <1.1 cm for a 1 cm disc impregnated with the desired compound). table ft1 table-wrap mode="anchored" t5 caption a7 MIC (μM) a S. aureus b MRSA c Open in a separate window 9a 7 ± 6 7± 3 Open in a separate window 9b 13 ± 7 13± 2 Open in a separate window 9c 101 ± 45 51 ± 15 Open in a separate window 9d 374 ± 187 374 ± 153 Open in a separate window 9e >715 >715 Open in a separate window 9f 3.2 ± 0.8 3.2 ± 0.9 Open in a separate window 9g >703 >703 Open in a separate window 9h >744 >744 Open in a separate window 9i 376 ± 217 376 ± 109 Open in a separate window 9j 1 ± 0.9 1 ± 0.7 Open in a separate window 9k(N5-pan) 7 ± 2 7 ± 2 Open in a separate window 9l (N9-pan) 0.4 ± 0.2 0.4 ± 0.2 Open in a separate window 9m 24 ± 14 24 ± 14 Open in a separate window a Minimum inhibitory concentrations (MICs) were determined using the following concentrations: 0.5, 1, 2, 4, 8, 16, 32, 64, 128, and 256 μg/mL.

Techniques:

Journal:

Article Title: Geminal dialkyl derivatives of N -substituted pantothenamides: Synthesis and antibacterial activity

doi: 10.1016/j.bmc.2011.02.053

Figure Lengend Snippet: Antibacterial activity of N -substituted pantothenamides 9a–9m

Article Snippet: A preliminary screen of these pantothenamides against other strains ( Acinetobacter baumannii ATCC 19606, Klebsiella penumoniae ATCC 13883, Escherichia coli ATCC 25922 and 11775, and Bacillus subtilis ATCC 6051 and 6633) using the agar diffusion method suggests no antimicrobial activity (inhibition zone <1.1 cm for a 1 cm disc impregnated with the desired compound). table ft1 table-wrap mode="anchored" t5 caption a7 MIC (μM) a S. aureus b MRSA c Open in a separate window 9a 7 ± 6 7± 3 Open in a separate window 9b 13 ± 7 13± 2 Open in a separate window 9c 101 ± 45 51 ± 15 Open in a separate window 9d 374 ± 187 374 ± 153 Open in a separate window 9e >715 >715 Open in a separate window 9f 3.2 ± 0.8 3.2 ± 0.9 Open in a separate window 9g >703 >703 Open in a separate window 9h >744 >744 Open in a separate window 9i 376 ± 217 376 ± 109 Open in a separate window 9j 1 ± 0.9 1 ± 0.7 Open in a separate window 9k(N5-pan) 7 ± 2 7 ± 2 Open in a separate window 9l (N9-pan) 0.4 ± 0.2 0.4 ± 0.2 Open in a separate window 9m 24 ± 14 24 ± 14 Open in a separate window a Minimum inhibitory concentrations (MICs) were determined using the following concentrations: 0.5, 1, 2, 4, 8, 16, 32, 64, 128, and 256 μg/mL.

Techniques: Activity Assay